Department of Ophthalmology, Technical University Munich, Munich, Germany.
Acta Ophthalmol. 2012 Sep;90(6):508-13. doi: 10.1111/j.1755-3768.2010.02052.x. Epub 2011 Jan 25.
To evaluate the safety, efficacy, predictability and stability of laser in situ keratomileusis (LASIK) with a 1000-Hz scanning spot excimer laser (Concept System 1000; WaveLight GmbH, Erlangen, Germany).
LASIK was performed on twenty eyes with myopia or myopic astigmatism (mean spherical equivalent refraction: -3.97±1.72 dioptres (D); mean cylinder: -0.84±0.77 D) using a microkeratome for flap creation and the Concept System 1000 for photoablation. Patients were examined preoperatively as well as 1, 3 and 6 months after the treatment. Manifest sphere and cylinder, uncorrected (UCDVA) and best corrected (BCDVA) distance visual acuity, corneal topography and pachymetry were analysed.
We observed no adverse events that might have been associated with the use of a repetition rate of 1000 Hz. All eyes maintained or had improved BCDVA at 6 months after treatment when compared to preoperative values. Six months after LASIK, UCDVA was 20/20 or better in 85% and 20/25 or better in 100% of the eyes. The spherical equivalent refraction was within ±0.50 D in 95% of the eyes at 6 months after surgery. The refraction stayed stable over time; 95% of the eyes changed<0.5 D postoperatively.
LASIK with the prototype 1000-Hz excimer laser was safe, efficient and predictable. The postoperative refraction was stable over time. There were no specific clinical side-effects that might be associated with the use of such a high repetition rate.
评估 1000Hz 扫描点准分子激光(Concept System 1000;WaveLight GmbH,Erlangen,德国)行 LASIK 的安全性、有效性、预测性和稳定性。
使用微型角膜刀制作角膜瓣,Concept System 1000 行光切削,对 20 只近视或近视散光眼(平均球镜等效屈光度:-3.97±1.72 屈光度(D);平均柱镜:-0.84±0.77 D)行 LASIK。术前及术后 1、3、6 个月对患者进行检查。分析角膜地形图、角膜厚度和视力。
我们未观察到与重复率 1000Hz 相关的不良反应。与术前相比,所有眼在术后 6 个月时均保持或提高了 BCDVA。术后 6 个月时,85%的眼 UCDVA 达到 20/20 或更好,100%的眼达到 20/25 或更好。95%的眼术后 6 个月时等效球镜屈光度在±0.50D 以内。术后随时间推移,屈光度稳定;95%的眼术后改变<0.5D。
使用原型 1000Hz 准分子激光行 LASIK 安全、有效、可预测。术后屈光度随时间推移保持稳定。无与如此高的重复率使用相关的特定临床副作用。